Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
05/07/2024 | Press release | Distributed by Public on 05/07/2024 06:45
Please select the service you want to use:
Smartlinks | Brockhaus Technologies AG | Finance | Security Markets | Security Markets | Company News | Top Company News | Shareholders | Shareholder Meeting | Financial Services | Investment Services | Securities Issuers | Private Equity | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | XETRA | Cboe Off Exchange | SIGMA X MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact